Facilitated By

San Antonio Medical Foundation

MODULATION OF AUTOPHAGY: PHASE II STUDY OF VORINOSTAT PLUS HYDROXYCHLOROQUINE VS REGORAFENIB IN REFRACTORY METASTATIC COLORECTAL CANCER (MCRC)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Mahalingam,Devalingam
Funded by
CANCER PREVENTION & RESEARCH INST OF TX
Research Start Date
Status
Active
Clinical Care
Cancer